logo-loader
NASDAQ:ALLO

Allogene Therapeutics Inc

Receive alerts
Market:
NASDAQ
Price
0.70 USD
Day Change
-6.48%
Market Cap:
$241.11 m
52 weeks high
4.46
52 weeks low
0.69

In brief

Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.